No title
- Funded by Chan Zuckerberg Initiative
- Total publications:0 publications
Grant number: unknown
Grant search
Key facts
Disease
COVID-19Start & end year
N/AKnown Financial Commitments (USD)
$0Funder
Chan Zuckerberg InitiativePrincipal Investigator
Alexandra-Chloe Villani, Orit Rozenblatt-RosenResearch Location
United States of AmericaLead Research Institution
Broad Institute of MIT and HarvardResearch Priority Alignment
N/A
Research Category
Pathogen: natural history, transmission and diagnosticsResearch Subcategory
ImmunitySpecial Interest Tags
N/AStudy Type
UnspecifiedClinical Trial Details
N/ABroad Policy Alignment
PendingAge Group
UnspecifiedVulnerable Population
UnspecifiedOccupations of Interest
Unspecified
Abstract
Researchers will investigate the host immune and cellular response associated with COVID-19 infection, symptoms, and lethality. This project is being done in close collaboration with several investigators and clinicians at the Massachusetts General Hospital and the Brigham and Women's Hospital to use single-cell genomic pipelines to analyze 500 longitudinal blood samples from COVID-19 patients collected in the hospital setting, as well as tissue samples (lung, heart, liver) from 10 deceased patients. Data will be rapidly shared as de-identified datasets with the biomedical community, and researchers will work closely with experts to analyze the results to inform disease outcomes in COVID-19 patients.